A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL

Enrollment

174

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Osteoarthritis of Knee

Interventions

DRUG

LBSA0103 (BDDE cross-linked sodium hyaluronate gel)

Trial Locations (1)

Seoul National University Hospital, Seoul